Rotavirus Vaccine Enrolling by Invitation Phase 3 Trials for Infections, Rotavirus Prevention

IndicationsStatusPurposePhase
Enrolling by InvitationPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03367559Evaluate Immunogenicity, Safety, and Reactogenicity of RotavacĀ® in Healthy Infants Aged Between 6-8 Weeks in Vietnam